Baird Capital

Baird Capital makes venture capital, growth equity, and private equity investments in strategically targeted sectors around the world. Baird Capital’s venture team invests in early and expansion stage technology-enabled B2B services and healthcare companies. Having invested in more than 300 companies over its history, Baird Capital partners with entrepreneurs and leverages its executive networks to build exceptional companies. The venture team has partnered with many of today’s leading emerging businesses in the targeted sectors, including such companies as Accuri Cytometers, Interlace Medical, MI Bioresearch, NeuMoDx Molecular, Autobooks, and Strata Oncology.